# FDA recall D-0306-2026

> **Unichem Pharmaceuticals USA Inc.** · Class III · drug recall initiated 2026-01-21.

## Product

Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.

## Reason for recall

Tablets/Capsules Imprinted with Wrong ID

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0306-2026
- **Recalling firm:** Unichem Pharmaceuticals USA Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2026-01-21
- **Report date:** 2026-02-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** East Brunswick, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0306-2026

## Citation

> AI Analytics. FDA recall D-0306-2026. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0306-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*